We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ONCY market cap is 77.04M. The company's latest EPS is CAD -0.3783 and P/E is -2.75.
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -6.73M | -7.16M | -11.05M | -8.85M | -8.73M |
Net Income | -6.44M | -7.44M | -9.93M | -3.95M | -6.89M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -20.14M | -25.46M | -26.23M | -26.92M | -33.79M |
Net Income | -33.12M | -22.51M | -26.3M | -24.84M | -27.75M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Assets | 35.33M | 31.97M | 46.09M | 38.82M | 34.75M |
Total Liabilities | 9.58M | 9.73M | 17.07M | 11.26M | 11.78M |
Total Equity | 25.75M | 22.24M | 29.02M | 27.56M | 22.97M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Assets | 19.66M | 34.35M | 45.88M | 37.33M | 38.82M |
Total Liabilities | 19.77M | 9.59M | 9.78M | 10.83M | 11.26M |
Total Equity | -108k | 24.75M | 36.1M | 26.5M | 27.56M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Operating | -7.83M | -16.29M | -22.32M | -28.45M | -7.47M |
Investing | 6.67M | 13.46M | 20.23M | 20.22M | -46k |
Financing | 5.27M | 8.96M | 30.25M | 31.99M | 1.5M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Operating | -19.91M | -22.07M | -22.44M | -23.36M | -28.45M |
Investing | -11k | -29k | -286k | -20.4M | 20.22M |
Financing | 21.02M | 39.77M | 33.02M | 12.21M | 31.99M |
Market Cap | 77.04M |
Price to Earnings Ratio | -2.75 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 2.19 |
Price to Book Ratio | 2.77 |
Dividend Yield | - |
Shares Outstanding | 73.37M |
Average Volume (1 week) | 144.79k |
Average Volume (1 Month) | 197.4k |
52 Week Change | -34.38% |
52 Week High | 3.3942 |
52 Week Low | 0.883 |
Spread (Intraday) | 0.05 (4.55%) |
Company Name | Oncolytics Biotech Inc |
Address |
1167 kensington crescent nw, suite 210 calgary, alberta T2N 1X7 |
Website | https://www.oncolyticsbiotech.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions